We are pleased to announce that Pharm&Access has organized lectures for more than 500 doctors throughout Kazakhstan since March 2023. Our goal is to increase awareness on Duchenne muscular dystrophy and the diagnostic program of neuromuscular diseases.

#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #CentralAsia #SareptaTherapeutics #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany